APG Hosted Webinar Series: Overview of Hepatorenal Syndrome Type-1 (HRS-1)
November 16, 2021, 11 am – 12 pm PT
- Discuss the incidence, prevalence and economic impact of HRS-1 which may be of particular interest to at-risk capitated medical groups
- Review the new 2021 American Association for the Study of Liver Diseases (AASLD) guidance for the treatment of Hepatorenal Syndrome Type-1 (HRS-1)
- Provide an overview of the clinical data for an investigational product
Register here. (For APG Members Only!)
For more information about the webinar and speakers click here.
Presented by Mallinckrodt Pharmaceuticals